Evidence map›Paper›PMID 37033476›Full record

ReviewFrontiers in cellular and infection microbiology2023

Progress of polymer-based strategies in fungal disease management: Designed for different roles.

Siyu Wu, Wenlai Guo, Bo Li, Huidong Zhou, Hongqi Meng, Junyi Sun, Ruiyan Li, Deming Guo, Xi Zhang, Rui Li and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Siyu WuDepartment of Hand Surgery, The Second Hospital of Jilin University, Changchun, China.
Wenlai GuoDepartment of Hand Surgery, The Second Hospital of Jilin University, Changchun, China.
Bo LiDepartment of Cardiovascular Surgery, The Second Hospital of Jilin University, Changchun, China.
Huidong ZhouDepartment of Hand Surgery, The Second Hospital of Jilin University, Changchun, China.
Hongqi MengDepartment of Hand Surgery, The Second Hospital of Jilin University, Changchun, China.
Junyi SunChangchun American International School, Changchun, China.
Ruiyan LiOrthpoeadic Medical Center, The Second Hospital of Jilin University, Changchun, China.
Deming GuoOrthpoeadic Medical Center, The Second Hospital of Jilin University, Changchun, China.
Xi ZhangDepartment of Burn Surgery, The First Hospital of Jilin University, Changchun, China.
Rui LiDepartment of Hand Surgery, The Second Hospital of Jilin University, Changchun, China.
Wenrui QuDepartment of Hand Surgery, The Second Hospital of Jilin University, Changchun, China.
Second Affiliated Hospital of Jilin University · CNJilin University · CNJilin International Studies University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal diseases have posed a great challenge to global health, but have fewer solutions compared to bacterial and viral infections. Development and application of new treatment modalities for fungi are limited by their inherent essential properties as eukaryotes. The microorganism identification and drug sensitivity analyze are limited by their proliferation rates. Moreover, there are currently no vaccines for prevention. Polymer science and related interdisciplinary technologies have revolutionized the field of fungal disease management. To date, numerous advanced polymer-based systems have been developed for management of fungal diseases, including prevention, diagnosis, treatment and monitoring. In this review, we provide an overview of current needs and advances in polymer-based strategies against fungal diseases. We high light various treatment modalities. Delivery systems of antifungal drugs, systems based on polymers' innate antifungal activities, and photodynamic therapies each follow their own mechanisms and unique design clues. We also discuss various prevention strategies including immunization and antifungal medical devices, and further describe point-of-care testing platforms as futuristic diagnostic and monitoring tools. The broad application of polymer-based strategies for both public and personal health management is prospected and integrated systems have become a promising direction. However, there is a gap between experimental studies and clinical translation. In future, well-designed

Indexed as

Antifungal AgentsMycosesFungiHumansPolymersAntifungal AgentsPolymersantifungal agentsantimicrobial polymersbiomaterialdrug delivery systemmycoses

Identifiers

PMID37033476
PMCPMC10073610
OpenAlexW4353081439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.